Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 6, 2013 - Issue 3
Submit an article Journal homepage
196
Views
35
CrossRef citations to date
0
Altmetric
Review

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

R Douglas Bruce Yale University AIDS Program, New Haven, CT, USA. [email protected]; Yale University School of Public Health, New Haven, CT, USA; Yale University AIDS Program, New Haven, CT, USA. [email protected]; Yale University School of Public Health, New Haven, CT, USA
,
David E Moody Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA; Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA
,
Frederick L Altice Yale University AIDS Program, New Haven, CT, USA; Yale University School of Public Health, New Haven, CT, USA; Yale University AIDS Program, New Haven, CT, USA; Yale University School of Public Health, New Haven, CT, USA
,
Marc N Gourevitch New York University School of Medicine, Department of Population Health, New York, NY, USA; New York University School of Medicine, Department of Population Health, New York, NY, USA
&
Gerald H Friedland Yale University AIDS Program, New Haven, CT, USA; Yale University School of Public Health, New Haven, CT, USA; Yale University AIDS Program, New Haven, CT, USA; Yale University School of Public Health, New Haven, CT, USA
Pages 249-269 | Published online: 10 Jan 2014

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Saif-El-Din El-Akkad, Seonaid Nolan, Kanna Hayashi, Huiru Dong, MJ Milloy, Kora Debeck & Lianping Ti. (2023) Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada. Journal of Addictive Diseases 41:3, pages 204-212.
Read now
Rajiv Balyan, David Hahn, Henry Huang & Vidya Chidambaran. (2020) Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opinion on Drug Metabolism & Toxicology 16:2, pages 125-141.
Read now
Onyema Ogbuagu, Gerald Friedland & R. Douglas Bruce. (2016) Drug interactions between buprenorphine, methadone and hepatitis C therapeutics. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 721-731.
Read now
Juliusz Kosel, Piotr Bobik & Michał Tomczyk. (2016) Buprenorphine – the unique opioid adjuvant in regional anesthesia. Expert Review of Clinical Pharmacology 9:3, pages 375-383.
Read now

Articles from other publishers (31)

Gavin Bart, Mutaz Jaber, Le Minh Giang, Richard C. Brundage & P. Todd Korthuis. (2022) Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability. Drug and Alcohol Dependence 241, pages 109696.
Crossref
Gavin Bart, Le Minh Giang, Hoang Yen, James S. Hodges & Richard C. Brundage. (2021) Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. Drug and Alcohol Dependence 227, pages 109025.
Crossref
Nina Y. Yuan & Marcus Kaul. (2019) Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury. Journal of Neuroimmune Pharmacology 16:1, pages 90-112.
Crossref
Haneefa T. Saleem, Samuel Likindikoki, Claire Silberg, Jessie Mbwambo & Carl Latkin. (2021) Time-space constraints to HIV treatment engagement among women who use heroin in Dar es Salaam, Tanzania: A time geography perspective. Social Science & Medicine 268, pages 113379.
Crossref
Sara D. PullenChristi AckerHaemi KimMorgan MullinsPayton SimsHolly StrasbaughSamantha ZimmermanCarlos del RioVincent C. Marconi. (2020) Physical Therapy for Chronic Pain Mitigation and Opioid Use Reduction Among People Living with Human Immunodeficiency Virus in Atlanta, GA: A Descriptive Case Series. AIDS Research and Human Retroviruses 36:8, pages 670-675.
Crossref
Ken J Goh, Mindy CM Choong, Elizabeth HT Cheong, Shirin Kalimuddin, Sewa Duu Wen, Ghee Chee Phua, Kian Sing Chan & Salahudeen Haja Mohideen. (2020) Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from Coronavirus Disease 2019 (COVID-19) Infection. Annals of the Academy of Medicine, Singapore 49:3, pages 108-118.
Crossref
Sauzanne Khalilieh, Ka L. Yee, Rosa I. Sanchez, Kate Vaynshteyn, Li Fan, Shawn Searle, Mohammed Bouhajib & Marian Iwamoto. (2019) Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone. Clinical Pharmacology in Drug Development 9:2, pages 151-161.
Crossref
Fatemeh Chalabianloo, Andreas A. Westin, Eirik Skogvoll, Jørgen G. Bramness & Olav Spigset. (2019) Methadone serum concentrations and influencing factors: A naturalistic observational study. Psychopharmacology 236:11, pages 3159-3167.
Crossref
S. Monty Ghosh, Lydia Vezina, Alvis Yu, Abhishek Jariwala, Ronald Lim & Robert Tanguay. (2019) Exploring Slow Release Oral Morphine (SROM) As a Transition Bridge for Medium to High Doses of Methadone Conversion to Buprenorphine/Naloxone Sublingual: A Calgary Concept and Approach. Canadian Journal of Addiction 10:2, pages 18-24.
Crossref
Aaron S. Devanathan, Daijha J.C. Anderson, Mackenzie L. Cottrell, Erin M. Burgunder, Ashley C. Saunders & Angela D.M. Kashuba. (2019) Contemporary Drug–Drug Interactions in HIV Treatment . Clinical Pharmacology & Therapeutics 105:6, pages 1362-1377.
Crossref
Maryam Khazaee-Pool, Maryam Moeeni, Koen Ponnet, Arezoo Fallahi, Leila Jahangiri & Tahereh Pashaei. (2018) Perceived barriers to methadone maintenance treatment among Iranian opioid users. International Journal for Equity in Health 17:1.
Crossref
Brianna L. Norton, Matthew J. Akiyama, Philippe J. Zamor & Alain H. Litwin. (2018) Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy. Infectious Disease Clinics of North America 32:2, pages 347-370.
Crossref
Priyanka Amin & Antoine Douaihy. (2018) Substance Use Disorders in People Living with Human Immunodeficiency Virus/AIDS. Nursing Clinics of North America 53:1, pages 57-65.
Crossref
R Douglas Bruce, Jessica Merlin, Paula J Lum, Ebtesam Ahmed, Carla Alexander, Amanda H Corbett, Kathleen Foley, Kate Leonard, Glenn Jordan Treisman & Peter Selwyn. (2017) 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clinical Infectious Diseases 65:10, pages e1-e37.
Crossref
Catherine J. Lucas, Joanne Patel & Jennifer H. Martin. (2017) Predicting drug interactions in addiction treatment. Internal Medicine Journal 47:8, pages 872-878.
Crossref
Evan D. Kharasch. (2017) Current Concepts in Methadone Metabolism and Transport. Clinical Pharmacology in Drug Development 6:2, pages 125-134.
Crossref
Akshanth R. Polepally, Jennifer R. King, Bifeng Ding, Diana L. Shuster, Emily O. Dumas, Amit Khatri, Yi-Lin Chiu, Thomas J. Podsadecki & Rajeev M. Menon. (2016) Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers. Clinical Pharmacokinetics 55:8, pages 1003-1014.
Crossref
Jonathan R. Buchholz & Andrew J. Saxon. 2016. Treating Comorbid Opioid Use Disorder in Chronic Pain. Treating Comorbid Opioid Use Disorder in Chronic Pain 57 67 .
Panagiotis Vagenas, Marwan M. Azar, Michael M. Copenhaver, Sandra A. Springer, Patricia E. Molina & Frederick L. Altice. (2015) The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review. Current HIV/AIDS Reports 12:4, pages 421-436.
Crossref
Evan D. KharaschKaren J. ReginaJane BloodChristina Friedel. (2015) Methadone Pharmacogenetics. Anesthesiology 123:5, pages 1142-1153.
Crossref
Leslie Lappalainen, Seonaid Nolan, Sabina Dobrer, Cathy Puscas, Julio Montaner, Keith Ahamad, Huiru Dong, Thomas Kerr, Evan Wood & M.-J. Milloy. (2015) Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids. Addiction 110:8, pages 1330-1339.
Crossref
Sarah Gadel, Christina Friedel & Evan D. Kharasch. (2015) Differences in Methadone Metabolism by CYP2B6 Variants. Drug Metabolism and Disposition 43:7, pages 994-1001.
Crossref
Aishwarya Vijay, Alexander R. Bazazi, Ilias Yee, Adeeba Kamarulzaman & Frederick L. Altice. (2015) Treatment Readiness, Attitudes Toward, and Experiences with Methadone and Buprenorphine Maintenance Therapy Among People Who Inject Drugs in Malaysia. Journal of Substance Abuse Treatment 54, pages 29-36.
Crossref
David E. Moody, Fenyun Liu & Wenfang B. Fang. (2015) Azole Antifungal Inhibition of Buprenorphine, Methadone and Oxycodone In Vitro Metabolism. Journal of Analytical Toxicology 39:5, pages 374-386.
Crossref
Sauzanne Khalilieh, Hwa-Ping Feng, Ellen G. J. Hulskotte, Larissa A. Wenning & Joan R. Butterton. (2015) Clinical Pharmacology Profile of Boceprevir, a Hepatitis C Virus NS3 Protease Inhibitor: Focus on Drug–Drug Interactions. Clinical Pharmacokinetics 54:6, pages 599-614.
Crossref
Scott D. Campbell, Sarah Gadel, Christina Friedel, Amanda Crafford, Karen J. Regina & Evan D. Kharasch. (2015) Influence of HIV antiretrovirals on methadone N-demethylation and transport. Biochemical Pharmacology 95:2, pages 115-125.
Crossref
Ellen G. J. Hulskotte, R. Douglas Bruce, Hwa-Ping Feng, Lynn R. Webster, Feng Xuan, Wen H. Lin, Edward O’Mara, John A. Wagner & Joan R. Butterton. (2015) Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy. European Journal of Clinical Pharmacology 71:3, pages 303-311.
Crossref
Julie C. Lauffenburger, Christina L. Mayer, Roy L. Hawke, Kim L.R. Brouwer, Michael W. Fried & Joel F. Farley. (2014) Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database. European Journal of Gastroenterology & Hepatology 26:10, pages 1073-1082.
Crossref
R. Douglas Bruce, P. Winkle, J. M. Custodio, X. Wei, M. S. Rhee, B. P. Kearney, S. Ramanathan & Gerald H. Friedland. (2013) Investigation of the Interactions between Methadone and Elvitegravir-Cobicistat in Subjects Receiving Chronic Methadone Maintenance. Antimicrobial Agents and Chemotherapy 57:12, pages 6154-6157.
Crossref
J. P. Meyer, A. L. Althoff & F. L. Altice. (2013) Optimizing Care for HIV-Infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities. Clinical Infectious Diseases 57:9, pages 1309-1317.
Crossref
R. Douglas Bruce, Leo Beletsky, Sharon Stancliff & Sarah Bowman. (2013) The Reply. The American Journal of Medicine 126:11, pages e21-e22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.